Assessment rate of true dorsogluteal intramuscular drug injection using ultrasonography
Authors:
Open Access
- 27 June 2019
- journal article
- research article
- Published by Pakistan Journal of Medical Sciences in Pakistan Journal of Medical Sciences
- Vol. 35 (4) , 1132-1137
Abstract
Objective: Medications are generally administered by either the enteric or parenteral route. With parenteral administration, intramuscular (IM) is the preferred approach because it increases the bioavailability of the drug, acts more quickly than the enteric route. The aim of this study was to determine the rate of true dorsogluteal intramuscular drug injection and to determine the causes for application failures in practice by ultrasonography (US). Methods: The study was conducted from May 1 to May 30, 2017 in Giresun University Education and Research Hospital, Giresun, Turkey. We examined 60 patients who were administered dorsogluteal IM injection with a 38.1mm length needle. After the injection, localization of medications (whether intramuscular or subcutaneous adipose tissue [SAT]) was evaluated by Ultrasound. Results: Female/male ratio of the patients was 27/33, with a mean age of 39.78±2.16 years. Obese/normal weight ratio was 20/40. The mean dorsogluteal area SAT thickness of obese and normal weight patients were 32.34±2.17 mm and 20.85±1.20 mm, respectively. In 23 of the patients, IM injected drug was observed in the SAT, while it was observed in the IM area in 37 patients. Medication was observed in IM area in 37 of 50 patients who dorsogluteal region SAT thickness was appropriate (SAT thickness lower than 33.1mm) for IM injection while it was seen in SAT area in 13 patients. Conclusions: SAT thickness values are important if IM drug injection is to be administered correctly. Unsuccessful IM injections may be seen even in patients with appropriate SAT thicknesses. doi: https://doi.org/10.12669/pjms.35.4.313 How to cite this:Ozen O, Gunaydin M, Tosun A, Coskun ZU, Aytekin K, Takir S. Assessment rate of true dorsogluteal intramuscular drug injection using ultrasonography. Pak J Med Sci. 2019;35(4):1132-1137. doi: https://doi.org/10.12669/pjms.35.4.313 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Keywords
This publication has 11 references indexed in Scilit:
- Effective method for drug injection into subcutaneous tissueScientific Reports, 2017
- Ventrogluteal versus dorsogluteal site selection: A cross-sectional study of muscle and subcutaneous fat thicknesses and an algorithm incorporating demographic and anthropometric data to predict injection outcomeInternational Journal of Nursing Studies, 2017
- Availability of Thickness Estimation of the Subcutaneous Fat by Using the Near-infrared Ray Measuring DeviceInternational Journal of Nursing & Clinical Practices, 2016
- Administering intramuscular injections: How does research translate into practice over time in the mental health setting?Nurse Education Today, 2015
- Intended intramuscular gluteal injectionsJournal of Postgraduate Medicine, 2014
- Intramuscular injections: a review of best practice for mental health nursesJournal of Psychiatric and Mental Health Nursing, 2008
- Does obesity prevent the needle from reaching muscle in intramuscular injections?Journal of Advanced Nursing, 2007
- Computed tomographic measurement of gluteal subcutaneous fat thickness in reference to failure of gluteal intramuscular injections.2007
- Intramuscular injections into the buttocks: Are they truly intramuscular?European Journal of Radiology, 2006
- Intramuscular gluteal injections in the increasingly obese population: retrospective studyBMJ, 2006